AbbVie



Ebitda تغيير تاريخ
AbbVie USD 6.92B 258M 2024-12
Abbott USD 2.66B 265M 2024-12
ALKERMES USD 163.42M 40.22M 2024-12
Amgen USD 3.71B 265M 2024-12
AstraZeneca USD 5.26B 597M 2024-12
Biogen USD 754.8M 7.2M 2024-12
BioMarin Pharmaceutical USD 194.85M 18.43M 2024-12
Bristol-Myers Squibb USD 4.91B 445M 2024-12
Eisai JPY 37.6B 13.2B 2024-12
Eli Lilly USD 6.17B 1.27B 2024-12
Gilead Sciences USD 3.21B 651M 2024-12
GlaxoSmithKline GBP 2.08B 1.22B 2024-12
J&J USD 7.88B 1.76B 2025-03
Medtronic USD 2.44B 134M 2025-01
Merck USD 7.12B 1.06B 2024-12
Neurocrine Biosciences USD 152.1M 39.2M 2024-12
Novartis USD 5.19B 319M 2024-12
Pacira USD 50.78M 8.5M 2024-12
Perrigo USD 245.1M 49.4M 2024-12
Pfizer USD 4.71B 3.04B 2024-12
Regeneron Pharmaceuticals USD 1.06B 572.8M 2024-12
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 4.25B 2.22B 2024-09
UCB EUR 652M 105M 2024-06
Ultragenyx Pharmaceutical USD -113199000 10.03M 2024-12
United Therapeutics USD 383.4M 43.9M 2024-12
Vertex Pharmaceuticals USD 1.16B 24.5M 2024-12
Zoetis USD 894M 145M 2024-12



AbbVie - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Apr 2025.